Intragastric Balloons Market Expected to Show a Significant Growth During the Forecast Period 2022 – 2028

San Francisco, California , USA, Sept 23, 2022 — /EPR Network/ —

Intragastric Balloons Industry Overview

The global intragastric balloons market size was valued at USD 14.9 million in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 11.9% from 2021 to 2028.

The increasing prevalence of obesity is anticipated to drive market growth. Furthermore, the rise in demand for minimally invasive procedures is anticipated to further boost the market growth.

Obesity is a major health concern across the globe. The obesity pandemic is expected to continue increasing over the forecast period, thus fueling the market growth. For instance, according to the World Health Organization (2016) data, nearly 2 billion individuals were overweight, and out of which around 650 million were obese. In addition, it is estimated that, by 2025, 2.7 billion individuals will be overweight and around 1.0 billion will be obese. Despite the high prevalence of obesity and the wide acceptance of weight-loss surgical procedures (such as gastric bypass and sleeve gastrectomy) by healthcare professionals, merely 1% or 2% of the obese population is eligible for these surgeries leading to high mortality due to obesity. For instance, according to World Health Organization data, globally, nearly 2.8 million individuals die each year due to obesity or overweight. This high mortality is anticipated to fuel demand for alternate and minimally invasive procedures such as an intragastric balloon.

Gather more insights about the market drivers, restrains and growth of the Global Intragastric Balloons market

The American Society for Metabolic and Bariatric Surgery (ASMBS) included the intragastric balloon in the list of procedures and devices approved by the society as a treatment option, in 2017. The sanction and endorsements of this treatment by the ASMBS is anticipated to increase the adoption of intragastric balloons. The high costs and procedural complications associated with aspiration therapy and neuroblocking therapy is anticipated to increase the demand for intragastric balloons. Furthermore, the development of novel intragastric balloons to overcome the shortcomings of conventional balloons is anticipated to further boost market demand. For instance, the magnetic soft endoscopic capsule-inflated intragastric balloon developed in collaboration with Nanyang Technological University, Singapore, is a biocompatible, acid-resistant and robot system for weight loss, thus reducing the need for complex insertion tools and the likelihood of adverse effects.

Browse through Grand View Research’s Medical Devices Industry Research Reports.

  • Electrophysiology Devices Market – The global electrophysiology devices market size was valued at USD 5.6 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 10.94% from 2022 to 2030.
  • Glaucoma Surgery Devices Market – The global glaucoma surgery devices market size to be valued at USD 2.6 billion by 2027 and is expected to grow at a compound annual growth rate (CAGR) of 6.9% during the forecast period.

Intragastric Balloons Market Segmentation

Grand View Research has segmented the intragastric balloons market on the basis of administration, balloon type, filling material, end use, and region:

Intragastric Balloons Administration Outlook (Revenue, USD Million, 2016 – 2028)

  • Pill Form
  • Endoscopy

Intragastric Balloons Type Outlook (Revenue, USD Million, 2016 – 2028)

  • Single
  • Dual
  • Triple

Intragastric Balloons Filling Material Outlook (Revenue, USD Million, 2016 – 2028)

  • Saline Filled
  • Gas Filled

Intragastric Balloons End-use Outlook (Revenue, USD Million, 2016 – 2028)

  • Hospitals
  • Clinics
  • Ambulatory surgical centers

Intragastric Balloons Regional Outlook (Revenue, USD Million, 2016 – 2028)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa (MEA)

Key Companies profiled:

Some prominent players in the global Intragastric Balloons market include

  • Apollo Endosurgery, Inc.
  • Obalon Therapeutics, Inc.
  • Allurion Technologies, Inc.
  • Spatz3
  • Helioscopie
  • Endalis
  • ReShape Medical, Inc.
  • Lexel Medical

Order a free sample PDF of the Intragastric Balloons Market Intelligence Study, published by Grand View Research.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.


Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519



Follow Us: LinkedIn | Twitter

Matched content

Editor’s pick

Express Press Release Distribution